Lara Goscé

480 total citations
23 papers, 247 citations indexed

About

Lara Goscé is a scholar working on Infectious Diseases, Epidemiology and General Health Professions. According to data from OpenAlex, Lara Goscé has authored 23 papers receiving a total of 247 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in General Health Professions. Recurrent topics in Lara Goscé's work include Tuberculosis Research and Epidemiology (11 papers), COVID-19 epidemiological studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Lara Goscé is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), COVID-19 epidemiological studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Lara Goscé collaborates with scholars based in United Kingdom, Switzerland and Germany. Lara Goscé's co-authors include Anders Johansson, David A. W. Barton, Ibrahim Abubakar, Rishi K Gupta, Paula Spinola, Kasim Allel, Hassan Haghparast‐Bidgoli, Helen R. Stagg, Graham S. Taylor and Peter Nguhiu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and European Respiratory Journal.

In The Last Decade

Lara Goscé

20 papers receiving 240 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lara Goscé United Kingdom	7	113	63	50	47	36	23	247
Paulo Vitor do Carmo Batista Brazil	2	200 1.8×	34 0.5×	53 1.1×	74 1.6×	18 0.5×	3	273
Shohei Nagata Japan	7	142 1.3×	83 1.3×	40 0.8×	40 0.9×	137 3.8×	14	438
Marc Massetti France	4	166 1.5×	53 0.8×	65 1.3×	61 1.3×	6 0.2×	5	273
Jessica P. J. Larwood United Kingdom	2	79 0.7×	30 0.5×	16 0.3×	38 0.8×	14 0.4×	4	270
Rebecca A. Stern United States	7	57 0.5×	45 0.7×	61 1.2×	41 0.9×	10 0.3×	10	342
Garyfallos Konstantinoudis United Kingdom	12	151 1.3×	86 1.4×	73 1.5×	56 1.2×	48 1.3×	22	542
Alice Harpur United Kingdom	5	241 2.1×	119 1.9×	56 1.1×	90 1.9×	8 0.2×	6	364
Anthea L Katelaris Australia	9	105 0.9×	84 1.3×	95 1.9×	22 0.5×	8 0.2×	15	374
Hakjun Hyun South Korea	10	69 0.6×	208 3.3×	84 1.7×	32 0.7×	9 0.3×	38	379
Danting Luo China	5	156 1.4×	56 0.9×	13 0.3×	27 0.6×	15 0.4×	9	389

Countries citing papers authored by Lara Goscé

Since Specialization

Citations

This map shows the geographic impact of Lara Goscé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lara Goscé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lara Goscé more than expected).

Fields of papers citing papers by Lara Goscé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lara Goscé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lara Goscé. The network helps show where Lara Goscé may publish in the future.

Co-authorship network of co-authors of Lara Goscé

This figure shows the co-authorship network connecting the top 25 collaborators of Lara Goscé. A scholar is included among the top collaborators of Lara Goscé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lara Goscé. Lara Goscé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ismail, Nazir, Harry Moultrie, Judith Mwansa-Kambafwile, et al.. (2025). Effects of conditional cash transfers and pre-test and post-test tuberculosis counselling on patient outcomes and loss to follow-up across the continuum of care in South Africa: a randomised controlled trial. The Lancet Infectious Diseases. 25(7). 764–774. 2 indexed citations

Schwalb, Alvaro, Katherine C. Horton, Jon C. Emery, et al.. (2025). Potential impact, costs, and benefits of population-wide screening interventions for tuberculosis in Viet Nam: A mathematical modelling study. PLOS Global Public Health. 5(9). e0005050–e0005050.

Blackstone, James, Oliver Stirrup, Natalie Adams, et al.. (2024). VIVALDI ASCOT and Ethnography Study: protocol for a mixed-methods longitudinal study to evaluate the impact of COVID-19 and other respiratory infection outbreaks on care home residents’ quality of life and psychosocial well-being. BMJ Open. 14(8). e088685–e088685. 2 indexed citations

Zenner, Dominik, Andrew Copas, Lara Goscé, et al.. (2024). Treatment of latent tuberculosis infection in migrants in primary careversussecondary care. European Respiratory Journal. 64(5). 2301733–2301733.

Ali, Shehzad, Seda Yerlikaya, Mary Gaeddert, et al.. (2024). Cost-effectiveness of diagnostic technologies for mycobacterium tuberculosis infection in India and Brazil. SHILAP Revista de lepidopterología. 4(11). e0003638–e0003638. 1 indexed citations

Goscé, Lara, Kasim Allel, Yohhei Hamada, et al.. (2024). Systematic review of the economic impact of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection compared with tuberculin skin test and interferon-gamma release assays. SHILAP Revista de lepidopterología. 4(10). e0003655–e0003655. 3 indexed citations

Adams, Natalie, Oliver Stirrup, James Blackstone, et al.. (2023). Shaping care home COVID-19 testing policy: a protocol for a pragmatic cluster randomised controlled trial of asymptomatic testing compared with standard care in care home staff (VIVALDI-CT). BMJ Open. 13(11). e076210–e076210. 1 indexed citations

Foster, Nicola, Amare Worku Tadesse, Christopher Finn McQuaid, et al.. (2023). Evaluating the equity impact and cost-effectiveness of digital adherence technologies with differentiated care to support tuberculosis treatment adherence in Ethiopia: protocol and analysis plan for the health economics component of a cluster randomised trial. Trials. 24(1). 292–292. 2 indexed citations

Goscé, Lara, Kasim Allel, Yohhei Hamada, et al.. (2023). Economic evaluation of novel Mycobacterium tuberculosis specific antigen-based skin tests for detection of TB infection: A modelling study. SHILAP Revista de lepidopterología. 3(12). e0002573–e0002573. 3 indexed citations

10.

Kelly, Sherrie L., Tom Palmer, Jolene Skordis, et al.. (2023). Public health benefits of shifting from hospital-focused to ambulatory TB care in Eastern Europe: Optimising TB investments in Belarus, the Republic of Moldova, and Romania. SHILAP Revista de lepidopterología. 3(6). e0001025–e0001025. 2 indexed citations

11.

Allel, Kasim, Lara Goscé, Rafael Araos, et al.. (2022). Transmission of gram-negative antibiotic-resistant bacteria following differing exposure to antibiotic-resistance reservoirs in a rural community: a modelling study for bloodstream infections. Scientific Reports. 12(1). 13488–13488. 7 indexed citations

12.

Baena, Inés García, Peter Nguhiu, Andrew Siroka, et al.. (2022). National tuberculosis spending efficiency and its associated factors in 121 low-income and middle-income countries, 2010–19: a data envelopment and stochastic frontier analysis. The Lancet Global Health. 10(5). e649–e660. 20 indexed citations

13.

Surey, Julian, Helen R. Stagg, Marc Lipman, et al.. (2021). An open label, randomised controlled trial of rifapentine versus rifampicin based short course regimens for the treatment of latent tuberculosis in England: the HALT LTBI pilot study. BMC Infectious Diseases. 21(1). 90–90. 8 indexed citations

14.

Goscé, Lara, Enrico Girardi, Kasim Allel, et al.. (2021). Tackling TB in migrants arriving at Europe’s southern border. International Journal of Infectious Diseases. 113. S28–S32. 3 indexed citations

15.

Hou, Xiaohui, Lara Goscé, Thomas Wilkinson, et al.. (2021). Improving Allocative Efficiency in Zimbabwe’s Health Sector. World Bank, Washington, DC eBooks. 2 indexed citations

16.

Goscé, Lara, et al.. (2020). Modelling SARS-COV2 Spread in London: Approaches to Lift the Lockdown. Journal of Infection. 81(2). 260–265. 40 indexed citations

17.

Copas, Andrew, Dominik Zenner, Lara Goscé, et al.. (2019). Protocol for a cluster randomised control trial evaluating the efficacy and safety of treatment for latent tuberculosis infection in recent migrants within primary care: the CATAPuLT trial. BMC Public Health. 19(1). 1598–1598. 2 indexed citations

18.

Goscé, Lara, et al.. (2019). BCG vaccination following latent TB treatment: Possible implications for different settings. International Journal of Infectious Diseases. 80. S17–S19. 5 indexed citations

19.

Goscé, Lara, et al.. (2019). Modelling the dynamics of EBV transmission to inform a vaccine target product profile and future vaccination strategy. Scientific Reports. 9(1). 9290–9290. 12 indexed citations

20.

Goscé, Lara, David A. W. Barton, & Anders Johansson. (2014). Analytical Modelling of the Spread of Disease in Confined and Crowded Spaces. Scientific Reports. 4(1). 4856–4856. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact